FNCE625 Investment Analysis and Portfolio Management

After 6 weeks on the job, you have been tasked to provide financial analysis on a specific company to the Board of Directors of your university.  The company under consideration is "Oramed Pharmaceuticals" (Symbol: ORMP).  Based on the knowledge gained in the course FNCE 625 (Investment Analysis), provide a financial report card on this company.  You may also provide a recommendation on whether you believe the University should buy or short sell the stock.   Highlight the key inputs and the basis for the assumptions in arriving to your conclusion.  Identify any factors that you believe would contribute to your financial analysis and the purchase or sale of the stock in the context of the overall UCW portfolio.

Instructions to Make Assignment

Executive Summary

Executive summary 

Financial Report Card

Make a financial report card of which should Include graphs and tables.(Includes 2 years trend of this company)

Recommendation for University to buy stock

Find out the current intrinsic value of the stock using CAPM (Capital Asset Pricing Model) and compare it with the prevailing market price. And then Recommend the university whether it should buy the stock or not.Mention the Reasons for buyig it or not as well

(Source of data to be used here is to be mentioned in Appendix and referred in the reference section. I would prefer you to use www.WSJ.Com(The Wall Street Journal) for finding the data.)

Factors And Conclusion

Identify any factors that you believe would contribute to your financial analysis and the purchase or sale of the stock in the context of the overall UCW portfolio.